Top-News

Aytu BioScience News

Keine aktuellen Kursdaten verfügbar
WKN: A2AJJ3
ISIN: US0547542052
Typ: Aktie

Aytu BioScience News

19.04.22 - PR Newswire
Thinking about buying stock in Aytu Biopharma, Casa Systems, Highpeak Energy, MRC Global, or DocGo?
Thinking about buying stock in Aytu Biopharma, Casa Systems, Highpeak Energy, MRC Global, or DocGo? PR Newswire
14.12.21 - PR Newswire
Denovo Biopharma LLC Announces Partner Aytu BioPharma Receives FDA Clearance and Orphan Drug Designation for Enzastaurin in Vascular Ehlers-Danlos Syndrome
Denovo Biopharma LLC Announces Partner Aytu BioPharma Receives FDA Clearance and Orphan Drug Designation for Enzastaurin in Vascular Ehlers-​Danlos Syndrome PR ...
24.12.20 - PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of AJRD, CATM, EXPC, GNBF, LNKB, NEOS, AYTU, QEP, FANG, RP, RNET, and VSAT
Lifshitz Law Firm, P.C. Announces Investigation of AJRD, CATM, EXPC, GNBF, LNKB, NEOS, AYTU, QEP, FANG, RP, RNET, and VSAT PR Newswire
16.12.20 - PR Newswire
NEOS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Neos Therapeutics, Inc. - NEOS
NEOS THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in ...
10.12.20 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Neos Therapeutics, Inc.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Neos Therapeutics, Inc. PR Newswire
10.12.20 - PR Newswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Neos Therapeutics, Inc.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Neos Therapeutics, Inc. PR Newswire
19.10.17 - PR Newswire
Aytu BioScience to Ring The NASDAQ Closing Bell Friday, October 20, 2017
Aytu BioScience to Ring The NASDAQ Closing Bell Friday, October 20, 2017 PR Newswire
18.10.17 - PR Newswire
Aytu BioScience Announces Uplisting to The NASDAQ Capital Market
Aytu BioScience Announces Uplisting to The NASDAQ Capital Market PR Newswire
09.10.17 - PR Newswire
Aytu BioScience Corporate Presentation is Now Available for On-Demand Viewing
Aytu BioScience Corporate Presentation is Now Available for On-Demand Viewing PR Newswire
28.09.17 - PR Newswire
Aytu BioScience to Webcast, Live, at VirtualInvestorConferences.com on October 5th
Aytu BioScience to Webcast, Live, at VirtualInvestorConferences.com on October 5th PR Newswire
28.09.17 - PR Newswire
Aytu BioScience Common Stock Resumes Trading under Symbol 'AYTU' Today
Aytu BioScience Common Stock Resumes Trading under Symbol 'AYTU' Today Temporary Ticker Symbol 'AYTUD' is No Longer Active as of September 28, 2017 PR Newswire
29.08.17 - PR Newswire
Aytu BioScience Announces Split-Adjusted Trading of its Common Stock
Aytu BioScience Announces Split-​Adjusted Trading of its Common Stock PR Newswire
25.08.17 - PR Newswire
Aytu BioScience Announces Reverse Split of its Common Stock
Aytu BioScience Announces Reverse Split of its Common Stock PR Newswire
24.08.17 - PR Newswire
Aytu BioScience to Provide Fiscal Fourth Quarter and Year-End 2017 Business Update
Aytu BioScience to Provide Fiscal Fourth Quarter and Year-End 2017 Business Update Live Conference Call and Webcast Scheduled for August 31, 2017, at 10:30 a.m. ET PR ...
11.08.17 - PR Newswire
Aytu BioScience, Inc. Announces $11.5 Million Private Placement
Aytu BioScience, Inc. Announces $11.5 Million Private Placement PR Newswire
13.07.17 - PR Newswire
Aytu BioScience Expands MiOXSYS® Distribution Network with a Fertility-Focused Company in Over 20 Countries in Europe
Aytu BioScience Expands MiOXSYS® Distribution Network with a Fertility-​Focused Company in Over 20 Countries in Europe PR Newswire
05.07.17 - PR Newswire
Aytu BioScience Presents Clinical Findings for its MiOXSYS® System at 33rd Annual Meeting of the European Society of Human Reproduction and Embryology
Aytu BioScience Presents Clinical Findings for its MiOXSYS® System at 33rd Annual Meeting of the European Society of Human Reproduction and Embryology PR Newswire
19.06.17 - PR Newswire
Aytu BioScience Announces the Appointment of Gregory A. Gould as Permanent Chief Financial Officer
Aytu BioScience Announces the Appointment of Gregory A. Gould as Permanent Chief Financial Officer PR Newswire
17.05.17 - PR Newswire
Aytu BioScience Presents New Research Findings for its Natesto® Testosterone Nasal Gel at 112th American Urological Association Annual Meeting
Aytu BioScience Presents New Research Findings for its Natesto® Testosterone Nasal Gel at 112th American Urological Association Annual Meeting PR Newswire
15.05.17 - PR Newswire
Aytu BioScience Presents New Research Findings for its MiOXSYS® System at 112th American Urological Association Annual Meeting
Aytu BioScience Presents New Research Findings for its MiOXSYS® System at 112th American Urological Association Annual Meeting PR Newswire

Newssuche

Videos

newspaper
23.04.24 -2,95%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »